{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:34Z","timestamp":1786991314511,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jagp.2021.07.002","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:48:20Z","timestamp":1625878100000},"page":"314-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-Label Extension of a Phase three Randomized Controlled Trial"],"prefix":"10.1016","volume":"30","author":[{"given":"Toshinari","family":"Odawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2021.07.002_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","article-title":"Dementia with Lewy bodies","volume":"3","author":"McKeith","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2021.07.002_bib0002","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","article-title":"A systematic review of prevalence and incidence studies of dementia with Lewy bodies","volume":"34","author":"Zaccai","year":"2005","journal-title":"Age Ageing"},{"key":"10.1016\/j.jagp.2021.07.002_bib0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2021.07.002_bib0004","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.JGP.0000216177.08010.f4","article-title":"More severe functional impairment in dementia with Lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction","volume":"14","author":"McKeith","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.07.002_bib0005","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/gps.4433","article-title":"Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease","volume":"31","author":"Svendsboe","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.07.002_bib0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/alzrt251","article-title":"Lewy body dementia: the impact on patients and caregivers","volume":"6","author":"Zweig","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jagp.2021.07.002_bib0007","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ncl.2017.01.004","article-title":"Lewy body disorders","volume":"35","author":"Galasko","year":"2017","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jagp.2021.07.002_bib0008","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/CON.0000000000000309","article-title":"Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia","volume":"22","author":"Gomperts","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jagp.2021.07.002_bib0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40266-018-00636-7","article-title":"Pharmacological management of dementia with Lewy bodies","volume":"36","author":"Hershey","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2021.07.002_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","article-title":"New evidence on the management of Lewy body dementia","volume":"19","author":"Taylor","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2021.07.002_bib0011","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-7091-0643-3_11","article-title":"The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease","volume":"65","author":"Bosboom","year":"2003","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.jagp.2021.07.002_bib0012","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/11594110-000000000-00000","article-title":"Treatment of dementia with Lewy bodies and Parkinson's disease dementia","volume":"28","author":"Ballard","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2021.07.002_bib0013","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4088\/JCP.v63n0608","article-title":"Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies","volume":"63","author":"Fernandez","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2021.07.002_bib0014","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11910-012-0290-7","article-title":"Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia","volume":"12","author":"Aarsland","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jagp.2021.07.002_bib0015","series-title":"The Clinical Practice Guidelines for Dementia","first-page":"237","article-title":"Japanese society of neurology task force on practice guidelines for dementia: chapter 7. Dementia with Lewy bodies","year":"2017"},{"key":"10.1016\/j.jagp.2021.07.002_bib0016","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/mds.26286","article-title":"Zonisamide improves wearing-off in Parkinson's disease: a randomized, double-blind study","volume":"30","author":"Murata","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2021.07.002_bib0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ncn3.12026","article-title":"Randomized placebo-controlled trial of zonisamide in patients with Parkinson's disease","volume":"4","author":"Murata","year":"2016","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.jagp.2021.07.002_bib0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0920-1211(95)00078-X","article-title":"Effects of zonisamide on dopaminergic system","volume":"22","author":"Okada","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jagp.2021.07.002_bib0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neures.2017.05.008","article-title":"Zonisamide inhibits monoamine oxidase and enhances motor performance and social activity","volume":"124","author":"Uemura","year":"2017","journal-title":"Neurosci Res"},{"key":"10.1016\/j.jagp.2021.07.002_bib0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2174\/1381612043453180","article-title":"Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease","volume":"10","author":"Murata","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jagp.2021.07.002_bib0021","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.pbb.2010.11.014","article-title":"Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats","volume":"97","author":"Miwa","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jagp.2021.07.002_bib0022","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neuropharm.2009.05.005","article-title":"Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway","volume":"57","author":"Yamamura","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jagp.2021.07.002_bib0023","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1440-1819.2010.02075.x","article-title":"Administration of zonisamide in three cases of dementia with Lewy bodies","volume":"64","author":"Odawara","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jagp.2021.07.002_bib0024","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1212\/WNL.0000000000005010","article-title":"Adjunct zonisamide to levodopa for DLB parkinsonism: a randomized double-blind phase 2 study","volume":"90","author":"Murata","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2021.07.002_bib0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.parkreldis.2019.12.005","article-title":"Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: a phase 3 randomized clinical trial","volume":"76","author":"Murata","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jagp.2021.07.002_bib0026","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2021.07.002_bib0027","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.parkreldis.2010.06.004","article-title":"Levodopa response in dementia with lewy bodies: a 1-year follow-up study","volume":"16","author":"Lucetti","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jagp.2021.07.002_bib0028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000017240","article-title":"One year follow-up of parkinsonism in dementia with Lewy bodies","volume":"11","author":"Ballard","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jagp.2021.07.002_bib0029","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1212\/WNL.43.8.1559","article-title":"Repeated exposure to the mini-mental state examination and the information-memory-concentration test results in a practice effect in Alzheimer's disease","volume":"43","author":"Galasko","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2021.07.002_bib0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-014-0081-2","article-title":"Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial","volume":"7","author":"Mori","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jagp.2021.07.002_bib0031","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000351672","article-title":"Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study","volume":"36","author":"Ikeda","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jagp.2021.07.002_bib0032","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.3390\/ijms20112842","article-title":"Frailty, cognitive decline, neurodegenerative diseases and nutrition interventions","volume":"20","author":"Gomez-Gomez","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121003857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121003857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:33:35Z","timestamp":1761021215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748121003857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1064748121003857"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2021.07.002","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-Label Extension of a Phase three Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2021.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of American Association for Geriatric Psychiatry.","name":"copyright","label":"Copyright"}]}}